Fierce Pharma June 30, 2022
Most pharma drug launches over the past three years have “underperformed expectations” and show the need for a major change in thinking about how to sell and market new meds.
That’s according to a new report, “Empowering the Next-Generation Launch Model,” out by life science consultants Trinity Life Sciences, which shows 62% of drug launches between September 2019 and December 2021 “underperformed expectations.”
These launches have not kept up with the “dramatic shifts” in scientific innovation over the last decade, the report found.